EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:167655 - BMS-214662
| Formula | C25H23N5O2S2 |
| Net Charge | 0 |
| Average Mass | 489.626 |
| Monoisotopic Mass | 489.12932 |
| SMILES | N#Cc1ccc2c(c1)CN(S(=O)(=O)c1cccs1)[C@H](Cc1ccccc1)CN2Cc1cncn1 |
| InChI | InChI=1S/C25H23N5O2S2/c26-13-20-8-9-24-21(11-20)15-30(34(31,32)25-7-4-10-33-25)23(12-19-5-2-1-3-6-19)17-29(24)16-22-14-27-18-28-22/h1-11,14,18,23H,12,15-17H2,(H,27,28)/t23-/m1/s1 |
| InChIKey | OLCWFLWEHWLBTO-HSZRJFAPSA-N |
| Roles Classification |
|---|
| Biological Roles: | EC 2.5.1.58 (protein farnesyltransferase) inhibitor An EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of protein farnesyltransferase (EC 2.5.1.58), one of the three enzymes in the prenyltransferase group. apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| BMS-214662 (CHEBI:167655) has role anti-anaemic agent (CHEBI:75835) |
| BMS-214662 (CHEBI:167655) has role antineoplastic agent (CHEBI:35610) |
| BMS-214662 (CHEBI:167655) has role apoptosis inducer (CHEBI:68495) |
| BMS-214662 (CHEBI:167655) has role EC 2.5.1.58 (protein farnesyltransferase) inhibitor (CHEBI:64133) |
| BMS-214662 (CHEBI:167655) is a benzenes (CHEBI:22712) |
| BMS-214662 (CHEBI:167655) is a benzodiazepine (CHEBI:22720) |
| BMS-214662 (CHEBI:167655) is a imidazoles (CHEBI:24780) |
| BMS-214662 (CHEBI:167655) is a nitrile (CHEBI:18379) |
| BMS-214662 (CHEBI:167655) is a sulfonamide (CHEBI:35358) |
| BMS-214662 (CHEBI:167655) is a thiophenes (CHEBI:26961) |
| IUPAC Name |
|---|
| (3R)-3-benzyl-1-(1H-imidazol-5-ylmethyl)-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carbonitrile |
| Synonyms | Source |
|---|---|
| (3R)-3-benzyl-1-(1H-imidazol-5-ylmethyl)-4-thiophen-2-ylsulfonyl-3,5-dihydro-2H-1,4-benzodiazepine-7-carbonitrile | ChEBI |
| Bms-214662 | ChEMBL |
| BMS 214662 | ChemIDplus |
| BMS214662 | ChemIDplus |
| (R)-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine-7-carbonitrile | ChEBI |
| (R)-7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:195987-41-8 | ChemIDplus |
| Citations |
|---|